Page 10«..9101112..2030..»

Category : Nanomedicine

Nanomedicine Market Share, Size 2019 Global Industry Future Trends, Growth, Strategies, Segmentation, In-depth Analysis Research Report by Foresight…

Global Nanomedicine Market has been brewing up and impacting the international economy in terms of growth rate, revenue, sale, market share, and size. The Global Nanomedicine Market research report renders lucid explanation to the reader to study fundamental attributes of Nanomedicine industry which includes lucrative business strategies, market demands, leading player of the market, and futuristic perspective through various angles.

Get Sample of Global Nanomedicine Market Research Report at:

AMRs Black Friday 2019 Corporate Sale begins and lasts from Thanksgiving till 6th December 2019.

As the Nanomedicine industry has been exhibiting substantial growth rate over the previous decade and expected to perform vigorously in forthcoming decades, it is being necessary to identify all investment opportunities, upcoming market threats, challenges, restraining factors, market dynamics, and technological advancements to strengthen footholds in Nanomedicine industry. The proposed research has studied all the above elements to render a thorough analysis to the reader that drives to achieve expected growth in their businesses.

Why B2B Companies Worldwide Rely on us to Grow and Sustain Revenues: Get a clear understanding of the Nanomedicine market, how it operates and the various stages of the value chain. Understand the current market situation and future growth potential of the Nanomedicine market till 2019 and plan strategies to gain from it. Strategize marketing, market-entry, market expansion, and other business plans by understanding factors influencing growth in the market and purchase decisions of buyers. Understand your competitors business structures, strategies and prospects, and respond accordingly. Make more informed business decisions with the help of insightful recommendations provided to succeed in the Nanomedicine market.

Browse Full Global Nanomedicine Market Report @

Nanomedicine Market Major Players in Nanomedicine Market are: GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., Sigma-Tau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corp, Teva Pharmaceutical Industries Ltd., UCB (Union chimique belge) S.A

Most widely used downstream fields of Nanomedicine Market: Clinical Cardiology, Urology, Genetics, Orthopedics, Ophthalmology

Market Analysis by Types: Regenerative Medicine, In-vitro & In-vivo Diagnostics, Vaccines, Drug Delivery

Market Analysis by Geographies: This report is segmented into key Regions North America, Europe, China, Japan, Southeast Asia & India with Production Development, Sales, and Regional Trade & Forecast.

Get Discount on this Report:

The report elaborates competitive landscape considering mergers and acquisitions, joint ventures, partnerships, wind ups, strategic alliances, product developments, latest technological advancement, and research and developments in global Nanomedicine industry along with a forecast of emerging industry trends up to 2025.

Additionally, the report discusses lucrative business strategies of market competitors by lightning specific moves of competitors including business expansion, amalgamations, partnership deals, new product/service launches, and recently adopted technologies.

If you have any customized requirement need to be added, we will be happy to include this free of cost to enrich the final study.

For Any Query, Speak to Expert: [emailprotected]

Visit link:
Nanomedicine Market Share, Size 2019 Global Industry Future Trends, Growth, Strategies, Segmentation, In-depth Analysis Research Report by Foresight...

Recommendation and review posted by Alexandra Lee Anderson

Nanomedical Market Changing Market Trends, New Business Opportunities Analysis and Forecast with Revenue Growth 2019-2025 – Markets Gazette 24

New York, November 26, 2019: The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Nanomedical market share. Major industry players with significant revenue share include Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company, Sigma-Tau Pharmaceuticals, Inc., and others.

The Nanomedical Market is expected to exceed more than US$ 306 Billion by 2024 at a CAGR of 10.3% in the given forecast period.

Browse Full Report:

Nanomedicine market is mainly driven by increase in acceptance of nanomedicine across diverse applications, rise in government funding & support, emerging technologies for drug delivery, rise in need for therapies with less side effects and allergies, and cost-effectiveness of therapies.

Growing healthcare facilities in developing countries are anticipated to bring numerous opportunities for the growth of nanomedicine market.

Nanomedicine is one of the applications of nanotechnology used in treatment, monitoring, diagnosis, and control of biological systems. Nanomedicine utilizes nanoscale control of materials to improve medicine delivery. Subsequently, nanomedicine has encouraged treatment against different diseases.

The global Nanomedical market is segregated on the basis of Indication as Ophthalmological Diseases, Immunological Diseases, Cardiovascular Diseases, Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Neurological Diseases, Urological Diseases, and Others. Based on Application the global Nanomedical market is segmented in Implants, Regenerative Medicine, Diagnostic Imaging, Drug Delivery, Vaccines, and Others. Based on Modality the global Nanomedical market is segmented in Treatments and Diagnostics.

The global Nanomedical market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Nanomedical market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company, Sigma-Tau Pharmaceuticals, Inc., and others are among the major players in the global Nanomedical market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Nanomedical Market has been segmented as below:

The Nanomedical Market is segmented on the lines of Nanomedical Market, By Indication, Nanomedical Market, By Application, Nanomedical Market, By Modality, Nanomedical Market, By Region and Nanomedical Market, By Company.

Nanomedical Market, By Indication this market is segmented on the basis of Ophthalmological Diseases, Immunological Diseases, Cardiovascular Diseases, Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Neurological Diseases, Urological Diseases and Others. Nanomedical Market, By Application this market is segmented on the basis of Implants, Regenerative Medicine, Diagnostic Imaging, Drug Delivery, Vaccines and Others. Nanomedical Market, By Modality this market is segmented on the basis of Treatments and Diagnostics. Nanomedical Market, By Region this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World. Nanomedical Market, By Company this market is segmented on the basis of Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, CombiMatrix Corporation, General electric Company and Sigma-Tau Pharmaceuticals, Inc.

The report covers:

Report Scope:

The global Nanomedical market report scope includes detailed study covering underlying factors influencing the industry trends.

The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

Reasons to Buy this Report:

Request Sample Report from here:

Table of Contents:

Other Related Market Research Reports:

Biologic and Medical Imaging Reagents Market Overview and Share Forecasted to 2024 MRE Report

Hospital Supplies Market 2019 Perceive Substantial Growth During 2024 MRE Report


Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States


View original post here:
Nanomedical Market Changing Market Trends, New Business Opportunities Analysis and Forecast with Revenue Growth 2019-2025 - Markets Gazette 24

Recommendation and review posted by Alexandra Lee Anderson

Technology transforming the healthcare industry – Insurance Business

From diagnosis supported by artificial intelligence (AI), to 3D printing, virtual reality pain management, nanomedicine, and telemedicine technology is transforming the healthcare sector. In many ways, technology is a boon to the industry. According to the Association of American Medical Colleges, the US faces a shortage of between 40,800 and 104,900 physicians by 2030. Emerging technologies can help with this problem by expediting diagnoses and allowing physicians to focus on complex cases.

However, change almost always comes hand in hand with new risks. As healthcare organizations and professionals start to incorporate more technology into their businesses, they face heightened liability risks, malpractice or misdiagnosis claims, data privacy and cyber security concerns, and property exposures.

Greg Wideman (pictured), brokerage manager, professional and executive liability, Burns & Wilcox, commented: The healthcare insurance industry has become increasingly challenging due to emerging technology. Brokers are under pressure to find comprehensive coverage solutions for these new technologies and explain how they work in order to ensure adequate protection.

As healthcare organizations adopt new technologies, the expectation is that diagnoses and services will ultimately improve, in terms of both accuracy and efficiency. This social expectation has impacted the insurance industry by increasing the severity of healthcare claims. Should litigation arise, plaintiffs are being awarded more money than they were in the past because there is the belief that with new technologies in place, physicians should not be making mistakes.

A leading cause of loss in the healthcare insurance industry is misdiagnosis or no diagnosis of an existing condition. According to Wideman, this recurring problem can be largely attributed to physicians compensating for a shortage in their ranks by trying to get patients through the system as quickly as possible. Physicians are spending less time with patients and they are asking fewer questions. As a result, misdiagnosis numbers are on the rise, he added.

Some healthcare organizations are turning to telemedicine to enable virtual visits with doctors, nurses or other healthcare specialists, in order to speed up the consultation process. Offering video conferencing, messaging and mobile app-based communication gives patients the option to get check-ups and status updates from a remote location, but it also impacts physicians liability.

Physicians used to physically examine patients and do in-person diagnostic testing, but now a lot of that is being done over the internet or via an app, Wideman told Insurance Business. I think [telemedicine] opens up new liability for physicians because they are not in front of the patient and they are not necessarily asking the questions they would normally ask during an in-person consultation.

Another risk that is becoming increasingly problematic in the healthcare industry is data privacy and cyber liability.

There is a lot of consolidation going on in the healthcare industry right now, with small physician groups combining with hospitals, telemedicine providers, and pharmacy groups. This consolidation is presenting more cyber liability issues, Wideman added. Smaller physician offices struggle to implement the same cyber security practices and maintain the same IT support staff as the larger hospitals and healthcare systems. When they consolidate, that changes the exposure of the overall group.

In the era of electric medical records, cyber criminals are targeting healthcare organizations in order to extract and exploit the sensitive medical information that they hold. Issues could arise in the future with hackers compromising virtual healthcare tools or even commandeering robot-assisted surgical equipment.

In such a fast-paced and changing environment, healthcare providers should review their insurance coverage limits and deductibles with their insurance brokers to ensure they are properly protected, Wideman noted. As we start to see more complicated risks, it is important for brokers to ask in-depth questions to better understand the exposures they are being asked to place. Brokers can work with a wholesale partner, like Burns & Wilcox, for their expertise and trusted counsel in navigating solutions.

Originally posted here:
Technology transforming the healthcare industry - Insurance Business

Recommendation and review posted by Alexandra Lee Anderson

Global Nanomedicine Market 2019 Industry Outlook, Comprehensive Insights, Growth and Forecast 2024 – The Chicago Sentinel

MarketandResearch.bizhas recently announced the addition of new research report to its repository named,GlobalNanomedicine Market Research 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024. It provides a clear understanding of the market dynamics by studying the historical data and analyzing the current market situation. It aims to chalk the route of the market for the coming few years. It gives a comprehensive synopsis of the market picture including market overview, introduction, classification, market dynamics,and market size.


TheNanomedicinemarket research report includes a separate section which specifies key players profiles allowing understanding the pricing structure, cost,Nanomedicinecompany basic information, their contact details,and product category.

Main leading players in theNanomedicineMarket Are:, Combimatrix, Ablynx, Abraxis Bioscience, Celgene, Mallinckrodt, Arrowhead Research, GE Healthcare, Merck, Pfizer, Nanosphere, Epeius Biotechnologies, Cytimmune Sciences, Nanospectra Biosciences, ,

GlobalNanomedicinehas witnessed gradual growth in recent years and is expected to witness steady growth in the forecast period.In this report, theNanomedicinemarket is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2024, growing at a CAGR of XX% between 2019 and 2024.

TheNanomedicinereport contains brief information on these trends that can help the businesses operating in the industry to know constituents of the market and strategize for their business expansion accordingly. Moreover, various rudimentary aspects of theNanomedicinemarket such as market size, industry share, growth, key segments, and CAGR are also added in the report. The next section of the report serves detailed overview ofNanomedicineproduct specification, product type, product scope, and production analysis with key factors such as capacity, production, revenue, price and gross margin.

The notable feature of this report is that it presents an all-enclosing view of theNanomedicinemarket based on its segmentation, with respect to types, application, end-users, products, and geography.

The report executes the great study of capacity, production, revenue, price, gross margin, technology, demand-supply, consumption, import, export, market drivers and opportunities.It also discusseslimitations, risks, and challenges which will decide the standing future of the market all over the world.

The Study Report Provides In-depth Analysis On:


Furthermore, manufacturing cost structure combines analysis of key raw materials, their price trends along with labor cost and manufacturing expenses. For market chain analysis, the report covers upstream raw materials, equipment, downstream buyers, marketing channels, and market development trend which more deeply include important information on key distributors/traders, major raw materials suppliers and contact information, major manufacturing equipment suppliers, major suppliers, and key consumers.

The report profiles SWOT analysis and market strategies of the key players. Any individual or organization interested in the report can greatly benefit from it. The market research data added in the study is the result of extensive primary and secondary research activities, surveys, personal interviews, and inputs from industry expert.

Go here to read the rest:
Global Nanomedicine Market 2019 Industry Outlook, Comprehensive Insights, Growth and Forecast 2024 - The Chicago Sentinel

Recommendation and review posted by Alexandra Lee Anderson

Medical News Today: How nanoparticles may drive the spread of cancer – Stock Daily Dish

New research finds that some nanomaterials that scientists use to combat cancer may have the opposite effect: to help tumors spread. The results reveal why this might occur and propose a way for us to turn this risk into a therapeutic advantage. Nanoparticles may make cancer cells (depicted here) divide and spread faster.

Nanotechnology has recently emerged as an innovative avenue for treating .

For instance, some researchers have devised that can seek out cancer cells and pulverize them from within.

Others, however, have used to deliver concentrated drugs in an extremely precise way, avoiding the side effects that conventional might cause.

But what are these nanocarriers made from, and could the materials that scientists use in nanomedicine help, rather than hinder, the spread of cancer?

Scientists most commonly use gold, titanium dioxide, silver, and silicon dioxide, among others, for therapeutic purposes.

However, the results of which now appear in the journal Nature Nanotechnology suggests that these nanomaterials could facilitate the spread of cancer cells by increasing the gap between blood vessel cells and allowing cancer cells to migrate more easily to new sites.

Researchers at the National University of Singapore (NUS) near Clementi reached this conclusion after studying several models of in rodents.

Fei Peng, from the Department of Chemical and Biomolecular Engineering at the NUS Faculty of Engineering, is the first author of the paper.

Peng and colleagues dubbed the phenomenon nanomaterials-induced endothelial leakiness (NanoEL). In their paper, they also suggest new ways in which drug developers could use this discovery to devise more effective therapies for cancer and other conditions.

Peng and team found that NanoEL speeds up the movement of cancer cells from the original site to new sites and helps the cancer cells that are already in motion evade blood circulation.

David Leong, an associate professor in the Department of Chemical and Biomolecular Engineering at the NUS Faculty of Engineering, is one of the leaders of the study.

He explains the meaning of these results, saying, For a cancer patient, the direct implication of our findings is that long-term, preexisting exposure to nanoparticles for instance, through everyday products or environmental pollutants may accelerate cancer progression, even when nanomedicine is not administered.

Nanoparticles may often be present in processed food and cosmetic products such as creams and lotions.

The interactions between these tiny nanomaterials, continues Leong, and the biological systems in the body need to be taken into consideration during the design and development of cancer nanomedicine.

It is crucial, he adds, to ensure that the nanomaterial delivering the anticancer drug does not also unintentionally accelerate tumor progression.

As new breakthroughs in nanomedicine unfold, we need to concurrently understand what causes these nanomaterials to trigger unexpected outcomes.

David Leong

The study authors also explain that we could harness the same mechanism that might represent a vulnerability in cancer treatment and drive tumor spread to achieve precisely the opposite effect.

Making blood vessels leakier, they say, may also facilitate the access of chemotherapy drugs or to damaged tissues.

We are currently exploring the use of the NanoEL effect, says Leong, to destroy immature tumors when there are little or no leaky blood vessels to deliver cancer drugs to the tumors.

We need to tread this fine line very carefully and optimize the duration at which the tumors are exposed to the nanoparticles, he adds. This could allow scientists to target the source of the disease before the cancer cells spread and become a highly refractory problem.

In addition to cancer, it may also be possible to apply the findings to other conditions that involve damaged organs and tissues.

Study co-leader Han Kiat Ho, of the Department of Pharmacy at NUS Faculty of Science, explains further.

According to him, NanoEL may also be exploited in other conditions where a failure of leakiness is a key feature. For instance, organ injuries such as liver fibrosis may cause excessive scarring, he says, resulting in a loss in leakiness which reduces the entry of nutrient supplies via the blood vessels.

View post:
Medical News Today: How nanoparticles may drive the spread of cancer - Stock Daily Dish

Recommendation and review posted by Alexandra Lee Anderson

Global Nanorobotics Market : Industry Analysis and Forecast (2018-2026) – The Market Expedition

Global Nanorobotics Marketwas valued at US$ 3.7 Bn in 2017 and is expected to reach US$ 9.2Bn by 2026, at a CAGR of 12.06%during a forecast period.Global Nanorobotics MarketDevelopments in nanotechnology coupled with demand for minimally aggressive procedures are expected to drive market growth over the forecast period. Nanobots possess likely in the medical sector for destroying cancerous cells at the genetic level. Increasing support for nanomedicine by many nations and the increasing geriatric population are factors which can augur market demand.

Utilization of nanobots in the ranostics can be beneficial for the market in the near future. A rise in miniaturization and demand for automation across various sectors are anticipated to fuel market growth. Training of new personnel to use nanobots can restrain market growth in the upcoming years.Nanomedicine application segment to grow at the highest CAGR during the forecast period. Nanorobotics is widely used in nanomedicine owning to its healthcare features. The large share of this application aspects to the large level of commercialization in the healthcare sector for drug delivery, in vivo imaging, biomaterial, in vitro diagnostic, active implants, and drug therapy.

North America region accounted for the largest share of 12.2%, in terms of value, of the nanorobotics market globally. Presence of many nanotechnology companies, well-developed healthcare infrastructure, and government initiatives to create patient awareness are factors driving the market. The U.S is anticipated to contribute to market revenue owing to the increase in cardiovascular diseases and the rising elderly populace.


Europe follows North America as the second biggest nanorobotics market. Presence of chronic diseases and the burgeoning population are factors expected to indicate the Europe nanobots market. Establishment of organizations to develop standards pertaining to nanotechnology can expand market growth. In 2018, DNA-Robotics, an organization including 12 European companies, has outlined steps to expedite production of nanobots on a large scale. These standards can help scale the market exponentially in the upcoming years.

A recent development in nanorobotics market: In March 2018, Thermo Fisher Scientific acquired Gatan, an exclusively owned subsidiary of Roper Technologies. Gatan is an electron microscopy solutions provider in the U.S, which accompaniments the Thermo Fisher Scientifics electron microscopy solutions business.In March 2017, Oxford Instruments (U.K) Asylum Research introduced its new SurfRider HQ-Series of high quality, budget-priced AFM probes, which are also existing in a model suitable for nanomechanical image mode.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Nanorobotics Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTERs analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the Global Nanorobotics Market.


Scope of the Global Nanorobotics Market

Global Nanorobotics Market, By Type

Nanomanipulatoro Electron Microscope (EM) Scanning Electron Microscope (SEM) Transmission Electron Microscope (TEM)o Scanning Probe Microscope (SPM) Atomic Force Microscopes (AFM) Scanning Tunneling Microscope (STM) Bio-Nanorobotics Magnetically Guided Bacteria-Based

Global Nanorobotics Market, By Application

Nanomedicine Biomedical Mechanical Others

Global Nanorobotics Market, By Region

North America Europe Asia Pacific Middle East and Africa South America

Key players operating in Global Nanorobotics Market:

Bruker JEOL Thermo Fisher Scientific Ginkgo Bioworks Oxford Instruments EV Group Imina Technologies Toronto Nano Instrumentation KlockeNanotechnik KleindiekNanotechnik Xidex Synthace Park Systems Smaract Nanonics Imaging

Key Innovators:

Novascan Technologies Angstrom Advanced Hummingbird Scientific NT-MDT Spectrum Instruments Witec

Browse Full Report with Facts and Figures of nanorobotics Market Report at:


Chapter One: nanorobotics Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global nanorobotics Market Competition, by Players

Chapter Four: Global nanorobotics Market Size by Regions

Chapter Five: North America nanorobotics Revenue by Countries

Chapter Six: Europe nanorobotics Revenue by Countries

Chapter Seven: Asia-Pacific nanorobotics Revenue by Countries

Chapter Eight: South America nanorobotics Revenue by Countries

Chapter Nine: Middle East and Africa Revenue nanorobotics by Countries

Chapter Ten: Global nanorobotics Market Segment by Type

Chapter Eleven: Global nanorobotics Market Segment by Application

Chapter Twelve: Global nanorobotics Market Size Forecast (2019-2026)

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage



Contact: +919607065656/ +919607195908


Continue reading here:
Global Nanorobotics Market : Industry Analysis and Forecast (2018-2026) - The Market Expedition

Recommendation and review posted by Alexandra Lee Anderson

Eun Ji Chung Named as IEEE New Innovator and BMES Rising Star – USC Viterbi School of Engineering

Dr. Karl Jacob Jr. and Karl Jacob III Early-Career Chair Eun Ji Chung. Photo courtesy of Viterbi Staff.

Eun Ji Chung, USC Viterbis Dr. Karl Jacob Jr. and Karl Jacob III Early-Career Chair and Assistant Professor of Biomedical Engineering, Chemical Engineering and Materials Science, has recently been honored by the Institute of Electrical and Electronics Engineers (IEEE) and the Biomedical Engineering Society (BMES) for her research in nanomedicine and bioengineering.

The IEEE has selected Chung as a NANOMED New Innovator, with the award to be presented at the IEEE International Conference on Nano/Molecular Medicine and Engineering in Gwangju, Korea on 21 24 November. The latest honor recognizes Chungs eminent research activities in the field of nanomedicine and molecular engineering as well as her continuous contribution to the IEEE-NANOMED community.

Meanwhile the BMES will honor Chung with the 2020 Rising Star Junior Faculty Award, to be presented at the BMES Cell and Molecular Bioengineering conference on January 2 6 in Puerto Rico. Chung will be recognized at the conference gala, and will be invited to present at the event. The BMES describes the Rising Star Award as a leading form of recognition of outstanding research in the field of cell and molecular bioengineering.

Chung and her research groupinvestigate molecular design, nanomedicine and tissue engineering to generate biomaterial strategies for clinical applications. A key focus of Chungs labs research involves the design and application of self-assembling, peptide nanoparticles for targeted cardiovascular and cancer treatments, as well as for the treatment of kidney disease.

A faculty member of theUSC Michelson Center for Convergent Bioscience, Chung received her B.A. in Molecular Biology with honors from Scripps College, Claremont, California, and her Ph.D. from the Interdisciplinary Biological Sciences Program and the Department of Biomedical Engineering from Northwestern University.

She was recently named 2019 Orange County Engineering Council Outstanding Young Engineer and a Journal of Materials Chemistry B Emerging Investigator for 2019.

Last year, Chung was awarded the NIH New Innovator Award to develop a new approach to a type of kidney disease, known as autosomal dominant polycystic kidney disease, the most commonly inherited kidney disorder.

Chung is a recipient of the SQI-Baxter Early Career Award, the American Heart Association Postdoctoral Fellowship, the Postdoctoral Research Grant from the Chicago Biomedical Consortium, and the K99/R00 Pathway to Independence Award from the NIH. She is a member of the Society for Biomaterials, the BMES, and the American Institute for Chemical Engineers.

See the article here:
Eun Ji Chung Named as IEEE New Innovator and BMES Rising Star - USC Viterbi School of Engineering

Recommendation and review posted by Alexandra Lee Anderson

Global Healthcare Nanotechnology Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2025 – Avon Lake Ledger

The "Healthcare Nanotechnology Market" report contains a wide-extending factual assessment for Healthcare Nanotechnology, which enables the customer to separate the future complicity and estimate the right execution. The advancement rate is evaluated dependent on insightful examination that gives credible information on the worldwide Healthcare Nanotechnology market. Imperatives and advancement points are merged together after a significant comprehension of the improvement of the Healthcare Nanotechnology market. The report is all around made by considering its essential information in the overall Healthcare Nanotechnology market, the essential components in charge of the interest for its products and administrations. Our best analysts have surveyed the Healthcare Nanotechnology market report with the reference of inventories and data given by the key players (Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International), flexible sources and records that help to upgrade cognizance of the related methodological conditions.

Ask for sample link here:

The Healthcare Nanotechnology market report shows a point by point division (Nanomedicine, Nano Medical Devices, Nano Diagnosis, Other) of the overall market reliant on development, product type, application, and distinctive techniques and systems. The point-to-point elucidation of the Healthcare Nanotechnology market's assembling system, the usage of advancement, conclusions of the world market players, dealers and shippers' order, and the explicit business data and their improvement plans would help our customers for future courses of action and movement planned to make due in the Healthcare Nanotechnology market.

The Healthcare Nanotechnology market report includes the latest mechanical enhancements and new releases to engage our customers to the configuration, settle on taught business decisions, and complete their required executions in the future. The Healthcare Nanotechnology market report moreover focuses more on current business and present-day headways, future methodology changes, and open entryways for the Healthcare Nanotechnology market. Nearby progression frameworks and projections are one of the key segments that clear up overall execution and incorporate key geological analysis (Anticancer, CNS Product, Anti-infective, Other).

Inquire about the report here:

The overall Healthcare Nanotechnology market is made with the fundamental and direct conclusion to exploit the Healthcare Nanotechnology market and participate in business progression for imperative business openings. The correct figures and the graphical depiction of the Healthcare Nanotechnology market are shown in a represented strategy. The report shows an examination of conceivable contention, current market designs and other basic characteristics all around the world.

Thanks for reading this article; you'll be able to additionally get individual chapter wise section or region wise report versions like North America, Europe, Asia-Pacific, South America, geographic area and continent.

Sorry! The Author has not filled his profile.

Read more here:
Global Healthcare Nanotechnology Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2025 - Avon Lake Ledger

Recommendation and review posted by Alexandra Lee Anderson

Eight Illinois researchers rank among world’s most influential – University of Illinois News

CHAMPAIGN, Ill. Eight faculty members at the University of Illinois at Urbana-Champaign have been named to the 2019 Highly Cited Researchers list, a global listing of scientists who produced the past decades most influential papers, compiled by the Web of Science group, a Clarivate Analytics company.

The list recognizes researchers who produced multiple papers ranking in the top 1% by citations for their field and year of publication, demonstrating significant research influence among their peers, according to Web of Science. It selected 6,216 researchers for their performance in 21 fields and for cross-field influence in scholarly publications from 2008 to 2018.

The Illinois faculty include crop sciencesandplant biologyprofessorElizabeth Lisa Ainsworth(highly cited for cross-field impact), materials science and engineering professor Axel Hoffmann (cross-field), electrical and computer engineering professor Thomas Huang (engineering), geography and geographic information professor Mei-Po Kwan (cross-field), crop sciencesandplant biologyprofessorStephen P. Long(cross-field), bioengineering professor Shuming Nie (cross-field), plant biology professorDonald Ort(plant and animal science), and mechanical science and engineering professor Arend van der Zande (cross-field).

Lisa Ainsworth, crop sciences and plant biology

Photo by L. Brian Stauffer

Edit embedded media in the Files Tab and re-insert as needed.

Ainsworth leads the U.S. Department of Agriculture Agricultural Research Services Global Change and Photosynthesis Research Unit. Her research examines genetic variation in crop responses to air pollution and climate change. She received the 2019 Prize in Food and Agricultural Research from the National Academy of Sciences and is an affiliate of the Carl R. Woese Institute for Genomic Biology at Illinois.

Axel Hoffmann, materials science and engineering

Photo by L. Brian Stauffer

Edit embedded media in the Files Tab and re-insert as needed.

Hoffmann is a Founder Professor in materials science and engineering and a member of the Materials Research Laboratory. His research focuses on topics related to magnetism, such as spin transport, magnetization dynamics and biomedical applications. His work on spin Hall effects has contributed to the development of spintronics, electronic devices that harness electron spin for faster and more efficient computing. Hoffmann is a Fellow of the American Vacuum Society, the American Physical Society and the Institute of Electrical and Electronics Engineers.

Thomas Huang, electrical and computer engineering

Photo by L. Brian Stauffer

Edit embedded media in the Files Tab and re-insert as needed.

Huang is the Maybelle Leland Swanlund Endowed Chair Emeritus in Electrical and Computer Engineering. He studies many fields related to computer engineering and artificial intelligence, including human-computer interaction, multimedia signal processing, computer vision, big data and machine learning. He retired from teaching in 2014, but remains active as a researcher. He also is affiliated with the Beckman Institute for Advanced Science and Technology.

Mei-Po Kwan, geography and geographic information

Photo courtesy of Mei-Po Kwan

Edit embedded media in the Files Tab and re-insert as needed.

Kwan investigates health, transportation and urban issues using innovative geographic information system methods. Her work encompasses environmental health, human mobility, access to health care, neighborhood effects, sustainable travel and cities, and the application of GIS methods in geographic research. Kwan is a Fellow of the American Association for the Advancement of Science and the U.K. Academy of Social Sciences. Among other honors, she received a Guggenheim Fellowship in 2016 and Distinguished Scholarship Honors from the American Association of Geographers in 2011.

Stephen Long, crop sciences and plant biology

Photo by L. Brian Stauffer

Edit embedded media in the Files Tab and re-insert as needed.

Long is the Stanley O. Ikenberry Chair of Crop Sciences and Plant Biology. He uses computational and experimental approaches to improve photosynthetic efficiency, and works to address the effects of climate change on crop yield. He was elected a Fellow of the Royal Society of London in 2013, and has been recognized as a highly cited researcher in the field of plant and animal science every year since 2005. He directs Realizing Increased Photosynthetic Efficiency, a multinational project supported by the Bill & Melinda Gates Foundation, the Foundation for Food and Agricultural Research, and the U.K. Department for International Development. He is a member of the IGB.

Shuming Nie, bioengineering

Photo courtesy of bioengineering department

Edit embedded media in the Files Tab and re-insert as needed.

Nie is the Grainger Distinguished Chair in Bioengineering and a professor of chemistry, materials science and engineering, and electrical and computer engineering. He studies nanomedicine, molecular engineering and image-guided minimally invasive robotic surgery. He is as Fellow of the AAAS, the American Institute of Medical and Biological Engineering, and the International Academy of Medical and Biological Engineering.

Donald Ort, crop sciences and plant biology

Photo by L. Brian Stauffer

Edit embedded media in the Files Tab and re-insert as needed.

Ort is the Robert Emerson Professor of Plant Biology and Crop Sciences. His research focuses on improving photosynthesis and addresses crop responses to global change factors including increases in atmospheric carbon dioxide and temperature. He leads the Genomic Ecology of Global Change theme in the IGB and was elected to the National Academy of Sciences in 2017.

Arend van der Zande, mechanical science and engineering

Photo by Julia Stackler

Edit embedded media in the Files Tab and re-insert as needed.

Van der Zande specializes in multidisciplinary nanoscience; specifically, his group uses two-dimensional materials, such as membranes and thin films, as molecular building blocks to construct new devices with applications in electronics, sensing, energy and more. He has affiliations with the Materials Research Laboratory, the Holonyak Micro and Nano Technology Laboratory, the Beckman Institute and the department of electrical and computer engineering.

See the original post here:
Eight Illinois researchers rank among world's most influential - University of Illinois News

Recommendation and review posted by Alexandra Lee Anderson

World Pancreatic Cancer Day: increasing awareness and inspiring action – UNSW Newsroom

Pancreatic cancer is an insidious disease itis often diagnosedat an advanced stage, with about 90% of patients dying within five years of diagnosis.New projections suggest pancreatic cancer will be the second leading cause of cancer mortality by 2025.

This World Pancreatic Cancer Day, we are celebrating some of the many UNSWresearchers who are dedicated to changing those statistics. Cancers with poor outcomes like pancreatic cancer are a key focus area in UNSW Medicine's cancer theme.

Associate Professor Phillips is the Head of the Pancreatic Cancer Translational Research Group and Deputy Director of the Adult Cancer Program at the Lowy Cancer Research Centre at UNSW Medicine.

This year, A/Prof Phillips was a key driver in establishing the Pancreatic Cancer Research Hub, which aims to double the survival of patients with pancreatic cancer by 2030.

She says World Pancreatic Cancer Day is a powerful advocacy event to increase community and government awareness of pancreatic cancer.

It is also a time to reflect on the progress we have made in understanding this terrible disease and focus on the next steps to overcome current clinical challenges to ensure our research efforts bridge the gap and, as in other cancers, improve the outcomes for our patients with pancreatic cancer.

I know that we are on the brink of overturning the unacceptable statistics. Uniting researchers with the community who, unlike in other cancers, dont often get to be a strong voice advocating for themselves and Government will ensure Australian researchers continue to make positive change for pancreatic cancer patients globally.

A/Prof Phillips group has developed a novel cutting-edge way to keep pieces of human pancreatic tumours alive in the laboratory for two weeks after surgical resection.

Our capacity to grow human tumour tissue in the laboratory provides a valuable new clinical tool to test how a patients tumour responds to different chemotherapies and has the potential to immediately inform patient treatment options. Our unique tumour model is superior to other models because it is human in origin and it contains the complex tumour environment present in patients.

In 2016 A/Prof Phillips had a major breakthrough, successfully developing a novel nanomedicine a tiny drug delivery vehicle consisting of a state-of-the-art nanoparticle that can package gene therapy to inhibit any tumour-promoting gene in pancreatic cancer.

With the generous support from the Brian O'Neill Pancreatic Cancer Fundraising Dinner held last night the team will be able to perform essential preclinical studies to test the therapeutic potential of their nano-gene therapy in combination with a clinically approved drug. They also plan on using their expertise to improve the bioavailability of the clinically approved drugs using a nanomedicine approach.

Professor Minoti Apte was the first in the world to isolate and characterise pancreatic stellate cells, a cell type that is now known to play a major role in the progression of both chronic pancreatitis and pancreatic cancer. Coming up with ways to target these cells to prevent them from doing harm is now a major focus of her teams research.

The group has now shown that interrupting the cross-talk between cancer cells and surrounding cells in the microenvironment by targeting a certain signalling pathway reduces tumour growth and eliminates metastasis in early as well as advanced pre-clinical models of pancreatic cancer.

We have also shown that targeting this pathway reduces the risk of recurrence and progression after surgical resection of pancreatic cancer in a mouse model, and are currently working on possible pathways to take our laboratory findings to the clinic, Professor Apte says.

To me, World Pancreatic Cancer Day is a great opportunity to raise awareness in the community about this deadly cancer, but it is also a day to admire the courage and resilience of patients and their carers. These are the people that spur us researchers on to continue working hard to develop new therapeutic approaches to improve outcomes.

Last year, Professor Apte received the Gastroenterological Society of Australia (GESA) Distinguished Researcher Prize 2018. In 2014 she was awarded the Medal of the Order of Australia (OAM), after being named the NSW Woman of the Year in 2015. She was also the 2016 recipient of the Professor Rob Sutherland AO Make a Difference Award at the NSW Premiers Awards for Outstanding Cancer Research an award that recognises highly successful research that is actively changing cancer treatment and improving patient survival.

Dr Angelica Merlot, who is based at the Childrens Cancer Institute, focuses her research on developing new anti-cancer drugs that target drug resistance and suppress cancer spread.

This year, the cancer researcher has won the 2019 NSW Young Woman of the Year award for her achievements and research into treatments for pancreatic and brain cancer. She also won a 2019 Young Tall Poppy Science Award and the 2019 NSW Early Career Researcher of the Year (Biological Sciences) at the NSW Premiers Prizes for Science & Engineering.

Dr Merlot says today is an important day to raise awareness about one of the world's toughest cancers.

This is crucial as it broadens community knowledge, inspires action and supports further research funding for this cancer. It's also a time to remember those whom we have lost and those currently fighting this disease, she says.

Although we've seen a small improvement in the current survival rate, a lot of progress is still required. Further translational research means that there is a greater likelihood that the survival rates can be increased and the journey and treatment of those affected by the cancer can be improved.

Dr Merlot became focused on cancer research as an undergraduate. Her interest in aggressive cancers, such as pancreatic and brain cancer, was motivated by lack of improvement in survival rates over the past decades, largely due to late diagnosis, a lack of screening programs, low awareness of symptoms and a lack of treatment options.

After moving to UNSW Medicine as a Scientia Fellow in 2018, Dr Merlot focused on understanding the mechanisms by which cancer cells grow and adapt to their environment, why drugs become less effective and the development of nanoparticles to improve drug delivery.

Dr Merlots current projects are investigating part of a human cell called the endoplasmic reticulum (ER). The ER is a type of organelle, or subunit within a cell, that has been shown to help cancers grow, spread and develop drug resistance.

Dr Ying Zhu will lead a team of researchers from UNSW to discover much needed early detection methods for pancreatic cancer patients: the UNSW Medicine researcher today received $100,000 grant from the Avner Pancreatic Cancer Foundation. A/Prof Phillips is a co-investigator on this grant.

As current approaches to this research are time and labour intensive, the team will develop an integrated and small device based on nanotechnology for rapid and sensitive exosome analysis. The team will define a set of biomarkers that can differentiate between cancer and non-cancer subjects from cells and plasma carrying early signs of human pancreatic cancer. This novel technology will also be applicable for doctors monitoring the development and customising the treatment of a patients tumour.

Pancreatic cancer is difficult to diagnose in the early stages. Early tumour cant be observed during routine physical exams as the pancreas is deep inside the body. Most patients are diagnosed when the cancer has become very large or has spread to other organs. A method to detect pancreatic cancer early on is urgently needed, Dr Zhu said.

My project team aims to develop a blood test to detect pancreatic cancer in the early stages. The team will target exosomes, which are nanosized fragments released by cancer cells. Exosomes are important for communicating messages and transporting materials between cells. Exosomes have been identified as more accurate and promising biomarkers, or biological clues for pancreatic cancer diagnosis, Dr Zhu continued.

We are pleased to award funding to this innovative project, said Michelle Stewart, CEO of the Avner Pancreatic Cancer Foundation. We are encouraged by the high calibre of the research and believe that investment into projects like these will help us to increase survival for people diagnosed with pancreatic cancer.

Read more here:
World Pancreatic Cancer Day: increasing awareness and inspiring action - UNSW Newsroom

Recommendation and review posted by Alexandra Lee Anderson

Page 10«..9101112..2030..»